Generex (GNBT) Announces FDA Price Approval for Generex Oral-lyn in the Treatment IND Program
Tweet Send to a Friend
Generex Biotechnology Corporation (Nasdaq: GNBT) announced that the FDA has granted price approval in respect of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
